James Neal - Jun 27, 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ James Neal by Neda Sharifi, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jun 27, 2023
Transactions value $
$0
Form type
4
Date filed
7/24/2023, 06:38 PM
Previous filing
Jun 13, 2023
Next filing
Nov 24, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +14.4K 14.4K Jun 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Options Exercise $0 -14.4K -100% $0.00* 0 Jun 27, 2023 Common Stock 14.4K $0.00 Direct F1
transaction PCSA Restricted Stock Award $0 +101K $0.00 101K Jun 27, 2023 Common Stock 101K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.